title: Inactivating STAT3: bad for tumor, good for muscle.
authors: a Department of Oncology ; IRCCS - Istituto di Ricerche Farmacologiche Mario Negri ; Milan , Italy.
authors: Rosanna
authors: R
authors: Piccirillo
authors: Raffaella
authors: R
authors: Giavazzi
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D002100:Cachexia / Q000517:prevention & control*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D009124:Muscle Proteins / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000187:drug effects*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011758:Pyrroles / Q000494:pharmacology*; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D009124:Muscle Proteins; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D050796:STAT3 Transcription Factor; D044767:Ubiquitin-Protein Ligases